Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with Type 1 diabetes

被引:81
作者
Chase, HP [1 ]
Saib, SZ [1 ]
MacKenzie, T [1 ]
Hansen, MM [1 ]
Garg, SK [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Dept Paediat, Denver, CO 80262 USA
关键词
Type; 1; diabetes; post-prandial glucose; bolus insulin;
D O I
10.1046/j.1464-5491.2002.00685.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To determine if one method of short-acting insulin bolus administration is superior to other methods in managing a meal high in carbohydrates, calories and fat. Methods Nine subjects receiving continuous subcutaneous insulin infusion using insulin lispro (Humalog(R)) agreed to consume the same meal high in carbohydrates, calories and fat on four occasions 1 week apart. They received the same dose of bolus insulin on each of the four occasions randomly assigned and beginning 10 min prior to the meal as either a single bolus, two separate boluses of one-half the same total dose (the second after 90 min), the entire bolus given as a square-wave (over 2 h) or a dual-wave (70% as a bolus and 30% as a square-wave over 2 h). Blood glucose levels were measured at -60 and -30 min and at zero time, and then every half-hour for 6 h using the Hemacue(R) in the out-patient clinic. Results Changes in blood glucose values from fasting were the lowest after 90 and 120 min (P<0.01) when the dual wave was administered. When the dual or square-wave methods of insulin administration were used, subjects had significantly lower glucose levels after 4 h in comparison with when the single or double boluses were used (P=0.04). Conclusions We conclude that the dual wave provided the most effective method of insulin administration for this meal. The dual- and square-wave therapies resulted in lower glucose levels 4 h after the meal in comparison with the single and double-bolus treatments.
引用
收藏
页码:317 / 321
页数:5
相关论文
共 31 条
[1]   Improved mealtime treatment of diabetes mellitus using an insulin analogue [J].
Anderson, JH ;
Brunelle, RL ;
Koivisto, VA ;
Trautmann, ME ;
Vignati, L ;
DiMarchi, R ;
Cameron, DP ;
Yeu, DK ;
Zimmet, P ;
Lauvaux, JP ;
VanGaal, LF ;
Chiasson, JL ;
Fettes, IM ;
Tan, MH ;
Toth, EL ;
Charbonnel, B ;
Selam, JL ;
Haslbeck, M ;
SchulzeSchleppinghoff, B ;
Karasik, A ;
Hazenberg, HJ ;
VanDoorn, LG ;
Bonnici, FB ;
Hough, S ;
Mollentze, WF ;
Moore, R ;
Omar, MA ;
Robertson, LI ;
VanRooyen, RJ ;
DeLeiva, A ;
Jara, A ;
Vazquez, JA ;
Arslanian, S ;
Bastyr, EJ ;
Bergenstal, RM ;
Blonde, L ;
Boyce, PA ;
Chase, HP ;
Clarke, DH ;
Davidson, J ;
Garber, A ;
Goldberg, RB ;
Guthrie, RA ;
Mayfield, RK ;
Mengel, MC ;
Prince, MJ ;
Reeves, ML ;
Rosenzweig, JL ;
Schade, DS ;
Soeldner, JS .
CLINICAL THERAPEUTICS, 1997, 19 (01) :62-72
[2]  
[Anonymous], 1997, S PLUS 4 GUID STAT
[3]   High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men -: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study [J].
Balkau, B ;
Shipley, M ;
Jarrett, RJ ;
Pyörälä, K ;
Pyörälä, M ;
Forhan, A ;
Eschwège, E .
DIABETES CARE, 1998, 21 (03) :360-367
[4]   Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men - The Rancho Bernardo Study [J].
Barrett-Connor, E ;
Ferrara, A .
DIABETES CARE, 1998, 21 (08) :1236-1239
[5]  
Borch-Johnsen K, 1999, LANCET, V354, P617
[6]  
Ceriello A, 1998, DIABETIC MED, V15, P188
[7]   POSTPRANDIAL VERSUS PREPRANDIAL BLOOD-GLUCOSE MONITORING IN WOMAN WITH GESTATIONAL DIABETES-MELLITUS REQUIRING INSULIN THERAPY [J].
DEVECIANA, M ;
MAJOR, CA ;
MORGAN, MA ;
ASRAT, T ;
TOOHEY, JS ;
LIEN, JM ;
EVANS, AT .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (19) :1237-1241
[8]   Impact of insulin lispro on HbA1c values in insulin pump users [J].
Garg, SK ;
Anderson, JH ;
Gerard, LA ;
Mackenzie, TA ;
Gottlieb, PA ;
Jennings, MK ;
Chase, HP .
DIABETES OBESITY & METABOLISM, 2000, 2 (05) :307-311
[9]  
Garg SK, 1996, DIABETIC MED, V13, P47, DOI 10.1002/(SICI)1096-9136(199601)13:1<47::AID-DIA999>3.0.CO
[10]  
2-M